Breast Cancer Update Home - Oncology Leader Commentary

Home: Oncology Leader Commentary: David Krag, MD

Click on the topic below for comments by Dr David Krag to comment on. You will also find links to related articles and clinical trials.

NSAPB sentinel node trial: Eligibility
NSAPB study
Immunohistochemistry
NSABP sentinel node trial: Survival endpoints
NSABP sentinel node trial: Morbiditiy endpoints
Morbidity of axillary dissection
NSABP sentinel node trial: Training surgeons to participate
Rationale for axillary dissection
NSABP sentinel node trial: Accrual
Should Sentinel node biopsies be done outside a clinical trial setting?
American College of Surgeons sentinel node trial

Home

Patrick I. Borgen, MD

Aman Buzdar, MD

Nancy E. Davidson, MD

J. Michael Dixon, MD

Armando Giuliano, MD

I. Craig Henderson, MD

David Krag, MD

Gershon Locker, MD

Charles Loprinzi, MD

Richard Margolese, MD

Monica Morrow, MD

C Kent Osborne, MD

Sir Richard Peto, FRS

Kathy I. Pritchard, MD

John F. Robertson, MD,FRCS

Andrew D. Seidman, MD

George W. Sledge, MD

Home · Contact us

Terms of use and general disclaimer